Several studies have reported transient neurological symptoms after spinal anaesthesia with 5% lignocaine. In order to evaluate the role of concentrated solutions of local anaesthetic in the development of transient neurological symptoms, 200 ASA I or II patients undergoing minor orthopaedic or rectal surgery under spinal anaesthesia were allocated randomly to receive 4% mepivacaine 80 mg or hyperbaric 0.5% bupivacaine 10 mg. All patients were interviewed by an anaesthetist approximately 24 h after spinal anaesthesia, and after 1 week patients were asked to return a written questionnaire. The incidence of transient neurological symptoms consisting of pain in the buttocks or pain radiating symmetrically to the lower extremities differed (P:0.001) between patients receiving mepivacaine (30%) and those receiving bupivacaine (3%). Hyperbaric 0.5% bupivacaine can be recommended for minor operations on the lower abdomen or lower extremities. (Br.
The first report of transient neurological symptoms, termed initially transient neurological impairment or transient radicular irritation, after spinal anaesthesia with hyperbaric 5% lignocaine by Schneider and colleagues in 1993 1 was confirmed later by several other studies. [2] [3] [4] [5] [6] It is thought that a localized local anaesthetic toxic effect may be an important contributing factor in the development of transient neurological symptoms after spinal anaesthesia with concentrated solutions. 7 8 The occurrence of this complication is rare after the use of 0.5% bupivacaine for spinal anaesthesia. 5 9 10 Mepivacaine has been used for spinal anaesthesia since the beginning of the 1960s. 11 In the first large-scale report of 20 000 mepivacaine spinal anaesthetics, outcome was favourable and no neurological complications were noted. 12 However, as with 5% hyperbaric lignocaine, the hyperbaric spinal anaesthetic solution of mepivacaine is also quite concentrated (4%) and post-spinal sequelae similar to those after hyperbaric lignocaine spinal anaesthesia should be expected. In this study, we examined the occurrence of transient neurological symptoms after spinal anaesthesia with either 4% hyperbaric mepivacaine or hyperbaric 0.5% bupivacaine.
Patients and methods
Two hundred ASA I or II patients undergoing minor orthopaedic, varicose vein, rectal or gynaecological operations were studied in a randomized, doubleblind manner (table 1) . Patients with a pre-existing neurological disease or diabetes mellitus were excluded. The study was approved by the Ethics Committee of the hospital, and informed consent was obtained from the patients.
All patients were premedicated with diazepam 5-15 mg orally. Patients were allocated randomly by sealed envelope to receive 4% mepivacaine 80 mg with glucose 95 mg ml 91 (Scandicain 40 mg ml 91 , Astra, Wedel, Germany) or 0.5% hyperbaric bupivacaine 10 mg with glucose 80 mg ml 91 (Marcain spinal 5 mg ml
91
, Tung, Astra, Södertälje, Sweden). An identical volume of 2 ml was drawn into a syringe by an independent anaesthesia nurse so that the anaesthetist (A. H.) performing the block was unaware of which drug was given. Although the doses are not equipotent from a theoretical point of view, similar spread and duration of spinal anaesthesia have been observed after a dose of 10 mg of 0.5 % hyperbaric bupivacaine and 80 mg of hyperbaric mepivacaine. 13 14 A peripheral i.v. infusion with acetated Ringer's solution was started before operation. Thereafter spinal anaesthesia was performed at the L3-4 interspace with the patient in the lateral position using a 27-gauge Quincke needle. However, if the puncture was considered difficult, a higher interspace, larger needle or the sitting position was chosen to perform spinal anaesthesia. Free flow of cerebrospinal fluid was verified before and after injection of the local anaesthetic. Immediately after spinal puncture, the patient was turned to the supine position with the operating table in a slight head-up tilt position.
Patients were monitored with electrocardiography, automated arterial pressure and pulse oximetry. Hypotension (systolic arterial pressure :90 mm Hg or 930% decrease from baseline) was treated with 5-mg increments of ephedrine or 200-g increments of phenylephrine. Bradycardia (heart rate :50 beat min 91 was treated with atropine 0.5 mg or glycopyrronium 0.2 mg.
Testing of pinprick analgesia and motor block was performed at 5, 10, 15, 60 min, and thereafter at 30-min intervals. A modified Bromage scale was used for testing motor block: 0:no paralysis (full flexion of the knees and feet), 1:inability to flex the extended leg (just able to move the knees), 2: inability to flex the knee (able to move the feet only), 3:inability to flex the ankle joint (unable to move the feet or knees). Patients were discharged from the recovery room when recovery of motor block was complete. Nurses on the ward recorded the time when patients reported that they had normal sensation in the buttocks and feet.
All patients were interviewed by the investigator on the first postoperative morning. They were asked if they had experienced any of the symptoms on the following standardized symptom checklist: headache, backache, pain not associated with surgery, sensory disturbances, change in muscle strength, or difficulties in voiding or in hearing. Special attention was paid to lower extremity symptoms, type of pain and radiation of pain. 3 One week after spinal anaesthesia, patients were asked to return a mailed questionnaire. They were asked to mention symptoms which they particularly associated with spinal anaesthesia. Enquiries concerning symptoms and their duration included headache, backache, pain in the operation area and pain in the thighs, buttocks, calves or elsewhere. Patients were also asked to assess the degree of satisfaction with their spinal anaesthesia.
Transient neurological symptoms were defined as symmetrical bilateral pain in the back or buttocks or pain radiating to the lower extremities after recovery from spinal anaesthesia.
Student's t test and Fisher's exact test were used to compare differences. P:0.05 was considered significant.
Results
The characteristics of the patients and details of the operations and spinal anaesthetic procedures are summarized in tables 1 and 2. Motor block was complete in 96% of patients in the mepivacaine group and in 81% of patients in the bupivacaine group (P:0.001). Details of motor block are presented in table 3. In one case, bupivacaine provided inadequate surgical anaesthesia although free flow of cerebrospinal fluid was verified before and after injection of the drug.
Eighty-nine of 99 (90%) patients in the mepivacaine group and 88 of 99 (89%) patients in the bupivacaine group returned the questionnaire. Twelve patients in the mepivacaine group and two patients in the bupivacaine group were not satisfied with their spinal anaesthesia (P:0.05). Two patients who had received mepivacaine spinal anaesthesia had headache at home, one for 3 days and the other for 1 week. Neither needed an extradural blood patch. Two patients who had received bupivacaine spinal anaesthesia reported transient deterioration in hearing.
The incidence of transient neurological symptoms differed (P:0.001) between patients who received In all three patients in the bupivacaine group and in 26 of 30 patients with symptoms in the mepivacaine group, pain occurred within the first 24 h. In one patient who had both pain and dysaesthesia in the buttocks, symptoms lasted for 5 days. In 14 patients in the mepivacaine group and in one patient in the bupivacaine group, pain was relieved by non-steroidal anti-inflammatory drugs; nine patients also needed opioids. Five patients reported that the pain was worse in the supine position and it was relieved when they stood up and started to walk (table 4) . No patient had sensory disturbances, change in muscle strength or difficulties in voiding on the first postoperative morning.
Three patients who had transient neurological symptoms after mepivacaine spinal anaesthesia had experienced similar symptoms before, one after 5% hyperbaric lignocaine spinal anaesthesia and two after 4% hyperbaric mepivacaine anaesthesia. All three patients who had transient neurological symptoms in the bupivacaine group returned the questionnaire and were satisfied with the spinal anaesthesia. In the mepivacaine group, 27 of 30 patients returned the questionnaire and 20% were not satisfied with spinal anaesthesia; four because of transient neurological symptoms, one because of painful puncture and one patient complained of difficulty in breathing because of the maximum height of block (T4) during operation.
All complaints were transient and had disappeared by the time the patients mailed the questionnaire.
Discussion
In this study, transient neurological symptoms occurred in 30% of patients who received spinal anaesthesia with mepivacaine but also in 3% of patients who received spinal anaesthesia with hyperbaric bupivacaine. However, duration of symptoms after bupivacaine spinal anaesthesia was less than 12 h compared with 12-120 h after mepivacaine spinal anaesthesia.
In 1993, Schneider and colleagues published the first case reports of transient neurological symptoms after spinal anaesthesia with 5% hyperbaric lignocaine. 1 Other later studies have shown similar symptoms, termed transient radicular irritation (TRI) after 5% hyperbaric lignocaine spinal anaesthesia in 10-37% of patients. [2] [3] [4] [5] Thus the incidence of transient neurological symptoms or TRI after concentrated solutions of 4% mepivacaine and 5% lignocaine is similar. In the study of Pollock and colleagues the incidence of TRI was 16% after both 5% hyperbaric lignocaine and 2% lignocaine without glucose, but 0% after 0.75% hyperbaric bupivacaine. 5 In the study by Tarkkila, Huhtala and Tuominen, only one of 110 patients had TRI after 0.5% hyperbaric bupivacaine. 10 The neurotoxic potential of 5% hyperbaric lignocaine and 0.75% bupivacaine has been evaluated. 7 Exposure of amphibian nerves to 0.75% isobaric bupivacaine produced partially reversible conduction block, whereas 5% lignocaine with or without glucose caused irreversible block of impulses. 7 Furthermore, it has been shown in an in vitro study that lignocaine 80 mmol, which is equivalent to a concentration of 2% lignocaine, caused complete ablation of impulse activity. 8 In clinical studies, decreasing the concentration of lignocaine from 5% to 2% did not prevent the development of TRI. 5 15 The doses of mepivacaine and bupivacaine in our study were based on the clinical study of Pitkänen, Kalso and Rosenberg, where 80 mg (2 ml) of 4% hyperbaric mepivacaine resulted in spinal anaesthesia similar to that after a dose of 0.5% hyperbaric bupivacaine 10 mg (2 ml) or 0.5% hyperbaric lignocaine 100 mg (2 ml).
14 Also, spinal anaesthesia with mepivacaine 60 mg produced analgesia and motor block of good quality but of short duration compared with spinal anaesthesia with 0.5% hyperbaric bupivacaine 15 mg. 16 Decreasing the dose of mepivacaine from 80 to 60 mg may diminish the development of transient neurological symptoms and still provide adequate anaesthesia for operations on the lower extremities.
Lambert, Lambert and Strichartz demonstrated synergistic neurotoxic effects of lignocaine and glucose in vitro, in frog sciatic nerve. 7 The loss of neural activity was not found to correlate with the glucose concentration and inhibition could not be induced without local anaesthetic. The hyperbaric mepivacaine solution has a higher concentration of glucose (95 mg ml ). The greater the baricity of the solution the greater the chance of gravitydetermined spread restriction. This, together with the use of small gauge pencil-point needles with one side hole near the tip, could result in pooling of the concentrated local anaesthetic solution. Repeated injections through thin intrathecal catheters may, therefore, result in cauda equina syndrome. 17 Beardsley and colleagues showed that sacral direction of the needle orifice and a slow injection rate with a Whitacre needle may be predisposing factors to transient neurological complications with 5% hyperbaric lignocaine. 18 However, other studies have failed to confirm this. 3 10 In contrast, in this study we injected via Quincke-type needles (orifice at the bevelled tip) and initial directional pooling of the local anaesthetic in the sacral region was unlikely.
In addition to a toxic effect of the local anaesthetic, the lithotomy position during surgery has been thought to be a possible cause of transient neurological symptoms. 1 4 10 The lithotomy position may contribute to transient neurological symptoms by stretching the cauda equina and sciatic nerves, thus decreasing the vascular supply and increasing vulnerability to injury. In our study, four patients in the bupivacaine group and two in the mepivacaine group were in the lithotomy position during surgery. Only one patient in the mepivacaine group had transient neurological symptoms starting 24-48 h after anaesthesia. However, transient neurological symptoms occurred in 22 patients undergoing arthroscopy of the knee. In our hospital, arthroscopy patients have both legs straight at the hip, and flexed 90Њ at the knee. The operative leg position is varied throughout surgery. The position and manipulation may contribute to neural stretching and thus to the development of transient neurological symptoms. Also, Pollock and colleagues found a higher incidence of transient neurological symptoms in patients undergoing arthroscopy than in those having inguinal hernia repair. 5 Individual physical characteristics of patients may predispose to the development of transient neurological symptoms after spinal anaesthesia. Interestingly, in this study three patients who had transient neurological symptoms after mepivacaine spinal anaesthesia had experienced similar symptoms before, one after 5% hyperbaric lignocaine and two after 4% hyperbaric mepivacaine spinal anaesthesia. It has been shown that the anatomical configuration of the spinal column affects the spread of subarachnoid anaesthetic solutions that move under the influence of gravity. 19 20 Both lumbar lordosis and thoracic kyphosis differ between individuals, particularly with respect to the lowest point of the thoracic spinal canal. 21 Musculoskeletal disturbances in the back and leg symptoms cannot be totally excluded. We speculate that profound relaxation of the supportive muscles of the lumbar spine may result in straightening of the lordotic curve, and even transient spondylolisthesis, when the patient is lying on the operating table. This may be responsible in part for the radiating back symptoms which occurred after the intense motor block, observed during mepivacaine spinal block in particular.
In summary, the incidence of transient neurological symptoms was greater after spinal anaesthesia with 4% hyperbaric mepivacaine than after 0.5% hyperbaric bupivacaine. Patients were more satisfied with bupivacaine spinal anaesthesia. Except for a greater number of complete motor blocks after mepivacaine, spinal anaesthesia and recovery were similar after both agents. Therefore, hyperbaric 0.5% bupivacaine 10 mg can be recommended for minor operations on the lower extremities or lower abdomen lasting less than 90 min.
